BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37166351)

  • 1. Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders.
    Lee S; Menzies L; Hay E; Ochoa E; Docquier F; Rodger F; Deshpande C; Foulds NC; Jacquemont S; Jizi K; Kiep H; Kraus A; Löhner K; Morrison PJ; Popp B; Richardson R; van Haeringen A; Martin E; Toribio A; Li F; Jones WD; Sansbury FH; Maher ER
    Hum Mol Genet; 2023 Nov; 32(22):3123-3134. PubMed ID: 37166351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlation at codon 1740 of SETD2.
    Rabin R; Radmanesh A; Glass IA; Dobyns WB; Aldinger KA; Shieh JT; Romoser S; Bombei H; Dowsett L; Trapane P; Bernat JA; Baker J; Mendelsohn NJ; Popp B; Siekmeyer M; Sorge I; Sansbury FH; Watts P; Foulds NC; Burton J; Hoganson G; Hurst JA; Menzies L; Osio D; Kerecuk L; Cobben JM; Jizi K; Jacquemont S; Bélanger SA; Löhner K; Veenstra-Knol HE; Lemmink HH; Keller-Ramey J; Wentzensen IM; Punj S; McWalter K; Lenberg J; Ellsworth KA; Radtke K; Akbarian S; Pappas J
    Am J Med Genet A; 2020 Sep; 182(9):2037-2048. PubMed ID: 32710489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation pattern and genotype-phenotype correlations of SETD2 in neurodevelopmental disorders.
    Chen M; Quan Y; Duan G; Wu H; Bai T; Wang Y; Zhou S; Ou J; Shen Y; Hu Z; Xia K; Guo H
    Eur J Med Genet; 2021 May; 64(5):104200. PubMed ID: 33766796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Heterogeneity and Different Phenotypes in Patients with
    Parra A; Rabin R; Pappas J; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; Santana A; Arroyo I; Artigas M; Pachajoa H; Alanay Y; Akgun-Dogan O; Ruaud L; Couque N; Levy J; Porras-Hurtado GL; Santos-Simarro F; Ballesta-Martinez MJ; Guillén-Navarro E; Muñoz-Hernández H; Nevado J; Spanish OverGrowth Registry Initiative ; Tenorio-Castano J; Lapunzina P
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.
    Bend EG; Aref-Eshghi E; Everman DB; Rogers RC; Cathey SS; Prijoles EJ; Lyons MJ; Davis H; Clarkson K; Gripp KW; Li D; Bhoj E; Zackai E; Mark P; Hakonarson H; Demmer LA; Levy MA; Kerkhof J; Stuart A; Rodenhiser D; Friez MJ; Stevenson RE; Schwartz CE; Sadikovic B
    Clin Epigenetics; 2019 Apr; 11(1):64. PubMed ID: 31029150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.
    Awamleh Z; Goodman S; Kallurkar P; Wu W; Lu K; Choufani S; Turinsky AL; Weksberg R
    Curr Protoc; 2022 Nov; 2(11):e597. PubMed ID: 36367395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders.
    Gillentine MA; Wang T; Hoekzema K; Rosenfeld J; Liu P; Guo H; Kim CN; De Vries BBA; Vissers LELM; Nordenskjold M; Kvarnung M; Lindstrand A; Nordgren A; Gecz J; Iascone M; Cereda A; Scatigno A; Maitz S; Zanni G; Bertini E; Zweier C; Schuhmann S; Wiesener A; Pepper M; Panjwani H; Torti E; Abid F; Anselm I; Srivastava S; Atwal P; Bacino CA; Bhat G; Cobian K; Bird LM; Friedman J; Wright MS; Callewaert B; Petit F; Mathieu S; Afenjar A; Christensen CK; White KM; Elpeleg O; Berger I; Espineli EJ; Fagerberg C; Brasch-Andersen C; Hansen LK; Feyma T; Hughes S; Thiffault I; Sullivan B; Yan S; Keller K; Keren B; Mignot C; Kooy F; Meuwissen M; Basinger A; Kukolich M; Philips M; Ortega L; Drummond-Borg M; Lauridsen M; Sorensen K; Lehman A; ; Lopez-Rangel E; Levy P; Lessel D; Lotze T; Madan-Khetarpal S; Sebastian J; Vento J; Vats D; Benman LM; Mckee S; Mirzaa GM; Muss C; Pappas J; Peeters H; Romano C; Elia M; Galesi O; Simon MEH; van Gassen KLI; Simpson K; Stratton R; Syed S; Thevenon J; Palafoll IV; Vitobello A; Bournez M; Faivre L; Xia K; ; Earl RK; Nowakowski T; Bernier RA; Eichler EE
    Genome Med; 2021 Apr; 13(1):63. PubMed ID: 33874999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel
    Wu Y; Liu F; Wan R; Jiao B
    Front Genet; 2023; 14():1153284. PubMed ID: 37025455
    [No Abstract]   [Full Text] [Related]  

  • 9. Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome.
    Lee S; Ochoa E; Badura-Stronka M; Donnelly D; Lederer D; Lynch SA; Gardham A; Morton J; Stewart H; Docquier F; Rodger F; Martin E; Toribio A; Maher ER; Balasubramanian M
    Eur J Hum Genet; 2023 Sep; 31(9):1040-1047. PubMed ID: 37407733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methylation episignatures in
    Lee S; Ochoa E; Barwick K; Cif L; Rodger F; Docquier F; Pérez-Dueñas B; Clark G; Martin E; Banka S; Kurian MA; Maher ER
    Epigenomics; 2022 May; 14(9):537-547. PubMed ID: 35506254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic features of luscan-lumish syndrome associated with a novel de novo variant of
    Zhang Y; Zhang H; Wu W; Wang D; Lv Y; Zhao D; Wang L; Liu Y; Zhang K
    Front Genet; 2023; 14():1081391. PubMed ID: 36777730
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular and molecular functions of SETD2 in the central nervous system.
    Mitchell B; Thor S; Piper M
    J Cell Sci; 2023 Nov; 136(21):. PubMed ID: 37921122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature.
    Rots D; Chater-Diehl E; Dingemans AJM; Goodman SJ; Siu MT; Cytrynbaum C; Choufani S; Hoang N; Walker S; Awamleh Z; Charkow J; Meyn S; Pfundt R; Rinne T; Gardeitchik T; de Vries BBA; Deden AC; Leenders E; Kwint M; Stumpel CTRM; Stevens SJC; Vermeulen JR; van Harssel JVT; Bosch DGM; van Gassen KLI; van Binsbergen E; de Geus CM; Brackel H; Hempel M; Lessel D; Denecke J; Slavotinek A; Strober J; Crunk A; Folk L; Wentzensen IM; Yang H; Zou F; Millan F; Person R; Xie Y; Liu S; Ousager LB; Larsen M; Schultz-Rogers L; Morava E; Klee EW; Berry IR; Campbell J; Lindstrom K; Pruniski B; Neumeyer AM; Radley JA; Phornphutkul C; Schmidt B; Wilson WG; Õunap K; Reinson K; Pajusalu S; van Haeringen A; Ruivenkamp C; Cuperus R; Santos-Simarro F; Palomares-Bralo M; Pacio-Míguez M; Ritter A; Bhoj E; Tønne E; Tveten K; Cappuccio G; Brunetti-Pierri N; Rowe L; Bunn J; Saenz M; Platzer K; Mertens M; Caluseriu O; Nowaczyk MJM; Cohn RD; Kannu P; Alkhunaizi E; Chitayat D; Scherer SW; Brunner HG; Vissers LELM; Kleefstra T; Koolen DA; Weksberg R
    Am J Hum Genet; 2021 Jun; 108(6):1053-1068. PubMed ID: 33909990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation episignature, extension of the clinical features, and comparative epigenomic profiling of Hao-Fountain syndrome caused by variants in USP7.
    van der Laan L; Karimi K; Rooney K; Lauffer P; McConkey H; Caro P; Relator R; Levy MA; Bhai P; Mignot C; Keren B; Briuglia S; Sobering AK; Li D; Vissers LELM; Dingemans AJM; Valenzuela I; Verberne EA; Misra-Isrie M; Zwijnenburg PJG; Waisfisz Q; Alders M; Sailer S; Schaaf CP; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2024 Mar; 26(3):101050. PubMed ID: 38126281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome.
    Kummeling J; Stremmelaar DE; Raun N; Reijnders MRF; Willemsen MH; Ruiterkamp-Versteeg M; Schepens M; Man CCO; Gilissen C; Cho MT; McWalter K; Sinnema M; Wheless JW; Simon MEH; Genetti CA; Casey AM; Terhal PA; van der Smagt JJ; van Gassen KLI; Joset P; Bahr A; Steindl K; Rauch A; Keller E; Raas-Rothschild A; Koolen DA; Agrawal PB; Hoffman TL; Powell-Hamilton NN; Thiffault I; Engleman K; Zhou D; Bodamer O; Hoefele J; Riedhammer KM; Schwaibold EMC; Tasic V; Schubert D; Top D; Pfundt R; Higgs MR; Kramer JM; Kleefstra T
    Mol Psychiatry; 2021 Jun; 26(6):2013-2024. PubMed ID: 32346159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETD2 histone modifier loss in aggressive GI stromal tumours.
    Huang KK; McPherson JR; Tay ST; Das K; Tan IB; Ng CC; Chia NY; Zhang SL; Myint SS; Hu L; Rajasegaran V; Huang D; Loh JL; Gan A; Sairi AN; Sam XX; Dominguez LT; Lee M; Soo KC; Ooi LL; Ong HS; Chung A; Chow PK; Wong WK; Selvarajan S; Ong CK; Lim KH; Nandi T; Rozen S; Teh BT; Quek R; Tan P
    Gut; 2016 Dec; 65(12):1960-1972. PubMed ID: 26338826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
    Aref-Eshghi E; Kerkhof J; Pedro VP; ; Barat-Houari M; Ruiz-Pallares N; Andrau JC; Lacombe D; Van-Gils J; Fergelot P; Dubourg C; Cormier-Daire V; Rondeau S; Lecoquierre F; Saugier-Veber P; Nicolas G; Lesca G; Chatron N; Sanlaville D; Vitobello A; Faivre L; Thauvin-Robinet C; Laumonnier F; Raynaud M; Alders M; Mannens M; Henneman P; Hennekam RC; Velasco G; Francastel C; Ulveling D; Ciolfi A; Pizzi S; Tartaglia M; Heide S; Héron D; Mignot C; Keren B; Whalen S; Afenjar A; Bienvenu T; Campeau PM; Rousseau J; Levy MA; Brick L; Kozenko M; Balci TB; Siu VM; Stuart A; Kadour M; Masters J; Takano K; Kleefstra T; de Leeuw N; Field M; Shaw M; Gecz J; Ainsworth PJ; Lin H; Rodenhiser DI; Friez MJ; Tedder M; Lee JA; DuPont BR; Stevenson RE; Skinner SA; Schwartz CE; Genevieve D; Sadikovic B
    Am J Hum Genet; 2020 Mar; 106(3):356-370. PubMed ID: 32109418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation episignature and comparative epigenomic profiling of HNRNPU-related neurodevelopmental disorder.
    Rooney K; van der Laan L; Trajkova S; Haghshenas S; Relator R; Lauffer P; Vos N; Levy MA; Brunetti-Pierri N; Terrone G; Mignot C; Keren B; de Villemeur TB; Volker-Touw CML; Verbeek N; van der Smagt JJ; Oegema R; Brusco A; Ferrero GB; Misra-Isrie M; Hochstenbach R; Alders M; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2023 Aug; 25(8):100871. PubMed ID: 37120726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
    Singh T; Kurki MI; Curtis D; Purcell SM; Crooks L; McRae J; Suvisaari J; Chheda H; Blackwood D; Breen G; Pietiläinen O; Gerety SS; Ayub M; Blyth M; Cole T; Collier D; Coomber EL; Craddock N; Daly MJ; Danesh J; DiForti M; Foster A; Freimer NB; Geschwind D; Johnstone M; Joss S; Kirov G; Körkkö J; Kuismin O; Holmans P; Hultman CM; Iyegbe C; Lönnqvist J; Männikkö M; McCarroll SA; McGuffin P; McIntosh AM; McQuillin A; Moilanen JS; Moore C; Murray RM; Newbury-Ecob R; Ouwehand W; Paunio T; Prigmore E; Rees E; Roberts D; Sambrook J; Sklar P; St Clair D; Veijola J; Walters JT; Williams H; ; ; ; ; Sullivan PF; Hurles ME; O'Donovan MC; Palotie A; Owen MJ; Barrett JC
    Nat Neurosci; 2016 Apr; 19(4):571-7. PubMed ID: 26974950
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tlemsani C; Luscan A; Leulliot N; Bieth E; Afenjar A; Baujat G; Doco-Fenzy M; Goldenberg A; Lacombe D; Lambert L; Odent S; Pasche J; Sigaudy S; Buffet A; Violle-Poirsier C; Briand-Suleau A; Laurendeau I; Chin M; Saugier-Veber P; Vidaud D; Cormier-Daire V; Vidaud M; Pasmant E; Burglen L
    J Med Genet; 2016 Nov; 53(11):743-751. PubMed ID: 27317772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.